Hybio Pharmaceutical Public
Hybio Pharmaceutical is a high-tech enterprise specializing in the research, development, production, and sales of polypeptide drugs. With a focus on strict production management and quality control, the company has successfully overcome the challenges of large-scale production of polypeptide drugs. They have applied for numerous patents, including patents for invention, and have obtained national new drug certificates and clinical trial permissions. Their drugs are used to treat a wide range of diseases, including digestive diseases, cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, tumors, and senile diseases.
Headquarters:
Shenzhen, Guangdong, China
Founded Date:
1998
Employee Number:
501-1000
Industry:
PharmTech
Investor Type:
Pharma Company